Characteristic | No LVH on echocardiogram n=176 | LVH on echocardiogram n=26 | P value* |
Median age (IQR) | 45 (39–52) | 51.5 (43–63) | <0.001 |
Female, n (%) | 93 (52.8) | 12 (46.2) | 0.52 |
Median BMI (IQR)† | 23.5 (20.9–26.8) | 28.3 (23.2–30.6) | 0.002 |
Median duration on ART (IQR)† | 6.8 (4.2–8.6) | 7.0 (5.6–10.4) | 0.06 |
Mean systolic blood pressure, mm Hg (SD) | 134 (23.4) | 169 (25.7) | <0.001 |
Mean diastolic blood pressure, mm Hg (SD) | 82 (14.2) | 94 (15.3) | <0.001 |
Blood pressure <140/90 mm Hg, n (%) | 100 (56.8) | 2 (7.7) | <0.001 |
Blood pressure 140–159 and/or90–99 mm Hg, n (%) | 46 (26.1) | 8 (30.8) | |
Blood pressure ≥160 and/or ≥100 mm Hg, n (%) | 30 (17.1) | 16 (61.5) |
*P values determined by χ2 and t-tests or rank-sum tests.
†BMI missing for one participant with LVH; duration on ART missing for one participant with no LVH.
ART, antiretroviral therapy; BMI, body mass index.